Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$444,384
+$136,481 QoQ
Shares Held
44,842
-10.7% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#66
of 183 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Shay Capital LLC holds $28,920,887 across 40 Biotechnology names. DNA ranks #18 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
80,000 | $3,763,200 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
44,000 | $3,586,440 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
12,500 | $2,341,000 | |
| 4 | MANE |
Veradermics, Inc
|
19,000 | $2,335,860 | |
| 5 | BCAX |
Bicara Therapeutics Inc.
|
68,000 | $2,018,920 | |
| 6 | QURE |
uniQure N.V.
|
37,419 | $1,723,519 | |
| 7 | AVLN |
Avalyn Pharma Inc.
|
40,000 | $1,316,800 | |
| 8 | PGEN |
Precigen, Inc.
|
190,000 | $1,083,000 |
All Filings in DNA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $444,384 | 44,842 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $307,903 | 50,229 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $364,800 | 43,899 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $309,066 | 21,198 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $218,047 | 19,382 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $104,070 | 18,258 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $222,609 | 22,669 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $44,508 | 133,258 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $51,377 | 44,291 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 DNABW | — | 127,596 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $45,717 | 27,052 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 DNABW | — | 114,786 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $48,964 | 27,052 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 DNABW | — | 94,622 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $54,408 | 29,252 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 DNABW | — | 92,075 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $38,905 | 29,252 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 DNABW | — | 87,425 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $23,999 | 14,201 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 DNABW | — | 54,617 | Shares | Sole | 2022-08-15 | |
| 2022-06-30 | $28,674 | 12,048 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||